Pfizer and Arvinas are poised to bring the third oral selective oestrogen receptor degrader (SERD) to market in the US, after ...

In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings.

CHICAGO — Chicago Cubs closer Daniel Palencia was activated from the 15-day injured list on Sunday after being sidelined by a left oblique strain.

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors ...

Kimi Antonelli has won the Miami Grand Prix for his third consecutive Formula 1 victory as the 19-year-old Mercedes drivers ...

Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.

NBA top rookie Cooper Flagg got a fast ride on the track before the NASCAR race in Texas with another 19-year-old, Cup Series ...

Pfizer will acquire Anacor Pharmaceuticals Inc. in a deal valued at about $5.2 billion. Anacor's topical treatment for eczema, called crisaborole, is currently under review by the Food and Drug ...

Is AZN a good stock to buy? We came across a bullish thesis on AstraZeneca PLC on South Sea Investing’s Substack. In this article, we will summarize the bulls’ thesis on AZN. AstraZeneca PLC’s share ...

Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in health care, consumer-facing ...

The U.S. Food and Drug Administration on Friday approved Pfizer ​and Arvinas' breast cancer drug for patients with an ...

When Evan Labelle talks about 3D printing, it’s less a business pitch and more a continuation of a lifelong habit: taking ...